Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii

INIS

• brain 16%
• cobalt 100%
• cobalt hydroxides 50%
• cobalt oxides 16%
• cobalt phosphates 16%
• comparative evaluations 33%
• conversion 16%
• cysts 33%
• damage 16%
• drugs 16%
• encephalitis 16%
• evaluation 16%
• field emission 16%
• host 50%
• human cells 16%
• inhibition 16%
• lactate dehydrogenase 16%
• morphology 16%
• nanoparticles 100%
• parasites 16%
• pathogens 16%
• scanning electron microscopy 16%
• size 33%
• toxicity 33%
• x-ray diffraction 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acanthamoeba 33%
• Acanthamoeba castellanii 100%
• Acanthamoeba Keratitis 16%
• Amoeba (Life Cycle Stage) 16%
• Antiamoebic 33%
• Antiinfective Agent 16%
• Brain Infection 16%
• Cyst (Resting Stage) 16%
• Cytotoxicity 33%
• Field Emission Scanning Electron Microscopy 16%
• Granulomatous Amebic Encephalitis 16%
• Infection 16%
• Infectious Agent 16%
• Lactate Dehydrogenase 16%
• Nanomedicine 16%
• Nanoparticle 100%
• Recurrent Disease 16%
• Trophozoite 33%